Hydroxyurea can eliminate transfusion requirements in children with severe β-thalassemia

Blood

Volumn 102, Issue 4, 2003, Pages 1529-1530

  Bradai, Mohamed ^b   Abad, Mohand Tayeb ^b   Pissard, Serge ^b   Lamraoui, Fatima ^b   Skopinski, Laurent ^b   De Montalembert, Mariane ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN; HYDROXYUREA;

ADOLESCENT; ANAPHYLAXIS; ARTICLE; BETA THALASSEMIA; BLOOD TRANSFUSION; CHILD; CHILL; CLINICAL ARTICLE; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFECT; FEMALE; FEVER; FOLLOW UP; GONADAL DISEASE; HEMOCHROMATOSIS; HEMOGLOBIN DETERMINATION; HUMAN; LIVER DISEASE; MALE; PRIORITY JOURNAL; SKIN DISEASE;

EID: 0042237715     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2003-01-0117     Document Type: Article

References (11)

1. Charache S, Terrin ML, Moore RD, et al. Effects of hydroxyurea on the frequency of painful crises in sickle cell anemia. N Engl J Med. 1995;332: 1317-1322.
2. De Montalembert M, Bégué P, Bernaudin F, Thuret I, Bachir D, Micheau M. Preliminary report of a toxicity study of hydroxyurea in sickle cell disease. Arch Dis Child. 1999;81:437-439.
3. Zeng YT, Huang SZ, Ren ZR, et al. Hydroxyurea therapy in β-thalassaemia intermedia: improvement in haematological parameters due to enhanced β-globin synthesis. Br J Haematol. 1995; 90:557-563.
4. Rigano P, Manfre L, La Galla R, et al. Clinical and hematological responses to hydroxyurea in a patient with Hb Lepore/beta-thalassemia. Hemoglobin. 1997;21:219-226.
5. Olivieri NF. Reactivation of fetal hemoglobin in patients with β-thalassemia. Semin Hematol. 1996;33:24-42.
6. Loukopoulos D, Voskaridou E, Stamoulakatou A, et al. Hydroxyurea therapy in thalassemia. Ann N Y Acad Sci. 1998;850:120-128.
7. Saxon BR, Rees D, Olivieri NF. Regression of extramedullary haemopoiesis and augmentation of fetal haemoglobin concentration during hydroxyurea therapy in β thalassaemia. Br J Haematol. 1998;101:416-419.
8. Hoppe C, Vichinsky E, Lewis B, Foote D, Styles L. Hydroxyurea and sodium phenylbutyrate therapy in thalassemia intermedia. Am J Hematol. 1999;62: 221-227.
9. Choudhry VP, Lal A, Pati HP, Arya LS. Hematological responses to hydroxyurea therapy in multi-transfused thalassemic children. Indian J Pediatr. 1997;64:395-398.
10. Cario H, Wegener M, Debatin KM, Kohne E. Treatment with hydroxyurea in thalassemia intermedia with paravertebral pseudotumors of extramedullary hematopoiesis. Ann Hematol. 2002; 81:478-482.
11. Arruda VR, Lima CSP, Saad STO, Costa FF. Successful use of hydroxyurea in β-thalassemia major. N Engl J Med. 1997;336:964.